Waystar Holding Corp.
WAY Healthcare Health Information Services
Waystar Holding Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 16.5% from fiscal 2024.
- Revenue
- +21.2%
- EPS
- −10.2%
- Free cash flow
- +23.4%
- Total debt
- +18.4%
Quarter to September 2026, against a year earlier
Follow WAY
Alert me
Waystar Holding Corp. (WAY) Shares outstanding
Waystar Holding Corp.'s shares outstanding at the end of fiscal 2025 was $184.8M, up 23.3% from $149.9M in fiscal 2024. At the end of the quarter to 30 September 2026 it was $195.9M. Waystar Holding Corp. ranks 3rd of 43 Health Information Services companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $184.8M | 23.26% |
| FY2024 | $149.9M | 23.21% |
| FY2023 | $121.7M | (0.01%) |
| FY2022 | $121.7M | — |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $195.9M | 0.72% |
| Jun 2026 | $194.5M | (0.33%) |
| Mar 2026 | $195.2M | 5.61% |
| Dec 2025 | $184.8M | 1.96% |
| 9 more quarters | Free account |
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| BTSG BrightSpring Health Services, Inc. compare | $220.2M |
| WAY Waystar Holding Corp. | $195.9M |
| DOCS Doximity, Inc. compare | $187.8M |
| TEM Tempus AI, Inc. compare | $181.3M |
| PRVA Privia Health Group, Inc. compare | $132.7M |
| HTFL Heartflow, Inc. compare | $86.4M |
| HQY HealthEquity, Inc. compare | $84.0M |
| HNGE Hinge Health Inc. compare | $83.4M |
| SDGR Schrodinger, Inc. compare | $74.9M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on WAY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Beneish M-score
- The full statement